Innovative Industrial Properties Inc Q2 FY2020 Earnings Call

Good morning, and welcome to Innovative Industrial Properties Second Quarter 2020 Earnings Call. Please note this event is being recorded. I would now like to turn the conference over to Brian Wolfe, General Counsel. Please go ahead.

Thank you for joining the call. Presenting today are Alan Gold, Executive Chairman; Paul Smithers, President and Chief Executive Officer; Catherine Hastings, Chief Financial Officer; and Ben Regin, Vice President of Investments. Before we begin, I'd like to remind everyone that statements made during today's conference call may be deemed forward-looking statements within the meaning of the safe harbor of the Private Securities Litigation Reform Act of 1995. And actual results may differ materially due to a variety of risks, uncertainties and other factors. For a detailed discussion of some of the ongoing risks and uncertainties of the company's business, I refer you to the news release issued yesterday and filed with the SEC on Form 8-K as well as the company's reports filed periodically with the SEC. The company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. I'll now hand the call over to Alan.

Thank you, Brian, and welcome, everyone, to our second quarter earnings call. First and foremost, we want to express our deep appreciation to all of our medical professionals, caregivers, and researchers who are on the front lines fighting the coronavirus pandemic we are experiencing across the globe. It has been a trying time over these many months as we continue to battle this health crisis and its resulting extreme economic disruption, but we are heartened by the advancements our health and science community has made in such a short period of time to understand this disease and formulate highly effective treatment plans for our patients and what we hope is a highly effective vaccine. As we discussed on our last call in May, the regulated cannabis industry, both medical and adult-use, was deemed an essential service by the vast majority of state and local jurisdictions in the United States. Our tenant operators have answered that call, adapting their operations in ways to ensure continued compassionate, individualized service to their patients and customers in an environment designed to maximize the safety and health of patients, customers, and employees. To recap our investments in support of the tremendous future of this industry, during the second quarter of 2020, we acquired 8 properties totaling over 775,000 square feet in 5 states and amended leases with our existing tenants for additional property improvements, collectively representing over $225 million of investments. These investments were comprised of both follow-on transactions with our existing tenant partners to facilitate their continued expansion, including industry-leading operators: Ascend Wellness, Cresco, Holistic, and Kings Garden; and new tenant relationships including Curaleaf and Columbia Care. Ben Regin, our Vice President of Investments, will discuss our recent acquisitions in more detail in our overall portfolio. As of today, we own 61 properties in 16 states totaling 4.5 million square feet, which are over 99% leased on a long-term basis to high-quality licensed cannabis operators. The one property that is not leased in our portfolio is our Los Angeles, California property with a tenant under receivership. As noted in our press release issued yesterday, Holistic Industries, our long-term tenant partner in Massachusetts, Maryland, and Pennsylvania, has entered into a definitive agreement to acquire the operational licenses for this property. We are optimistic regarding the completion of this transaction and partnering with Holistic again on a long-term basis for this property that will remain subject to customary closing conditions and final receivership court approval. As noted in our press release issued yesterday, aside from our Los Angeles property, our tenants have paid 100% of contractually due rent for each of the months of April, May, June, and July, including the 3/10 from which we provided temporary rent deferral in Q2. As of today, we have no other tenants under our rent deferral program, which we believe is a testament to the quality of our tenant base and their ability to adapt to this new normal. Reflecting the strength and resilience of our tenant partners, we paid a quarterly common stock dividend of $1.06 per share to shareholders on July 15, representing a 77% increase over our second quarter 2019 dividend, driven by our continued execution on our pipeline of acquisitions. This dividend was also supported by our tremendous 180% plus growth year-over-year in rental revenue, net income, and AFFO, which to note, does not take into account at all the 3 acquisitions we completed after quarter end, constituting $49 million of additional investments. The COVID-19 pandemic and severe economic disruption constitute the first recession faced by the regulated cannabis industry, and we believe our tenants have adapted exceptionally well to new ways of serving their patients and customers, which Paul will touch on later. On the financing front, I would also like to personally thank all of our shareholders, our long-term company owners, for their steadfast support, providing us over $370 million in gross proceeds over the last 3 months to support our long-term tenant partners and their continued expansion initiatives while forging additional partnerships with the top-tier operators in the industry. Catherine will also provide more detail regarding our financial results and capital raising activity. As always, we are focused on continuing to be long-term stewards of your investment in our company and navigating through the immense challenges posed by the health crisis and economic disruption. Despite these challenges, we continue to be strong believers in the resilience and potential of the still quite young industry and being a key real estate capital provider to enable its continued growth for many years to come. With that, I’d like to turn the call over to Paul.

Thanks, Alan. For this call, I plan to provide an update on the regulated cannabis industry with a focus on the COVID-19 pandemic including: one, the current regulatory environment for cannabis operators during this crisis; and two, the dynamics of the industry during this crisis and developments that we continue to monitor closely. As mentioned on our last call, I'd like to also preface this discussion, noting that regulations and industry developments are evolving rapidly. And while we want to provide you a general landscape as of now, there can be no assurance that this landscape will not significantly change. First, regarding the current regulatory environment as it pertains to the COVID-19 pandemic. As noted on our previous call, we continue to be in touch with each of our tenants during this pandemic, and we monitor state and local developments closely. In the vast majority of states, medical-use and adult-use cannabis have been determined by applicable government authorities to be essential businesses that can continue to operate as an exception to general state and local shutdown orders. The essential designation has generally been applied throughout the supply chain including cultivation, processing, packaging, distribution, and dispensing. There have been certain exceptions, however, such as in Massachusetts, where the governor permitted medical-use cannabis businesses to continue to operate as essential but shut down adult-use cannabis businesses as not essential for a period of time, allowing them to reopen in late May. As noted previously, over the long term, we see the clear, nearly uniform designation of medical-use cannabis businesses as essential during this crisis as a very positive point for the industry and offering further validation of the key importance of medical cannabis for patients in managing their medical conditions. And as we touched on in prior calls, pre-pandemic, 2020 was shaping up to be another watershed year on the state legalization front with as many as 11 states' residents expected to vote on medical or adult-use cannabis legalization. However, shelter-in-place orders greatly impacted the ability of organizers to gather sufficient signatures in person. And as a result, a number of the initiatives have been postponed. Even in the face of such challenges, a number of initiatives are moving forward including voter approval of an adult-use program in New Jersey, where we acquired 3 properties after the quarter end and in Arizona, where we own 2 properties. It appears likely that adult-use legalization will be on the ballot for November with organizers having collected over 420,000 signatures, over 180,000 more than what's required. Post-pandemic, we expect a strong long-term momentum of both medical-use and adult-use legalization across states to continue, if not increase, in line with clear shifts of opinions of citizens nationwide and the importance of supporting an industry that will serve as a key source of good-paying jobs, tax revenues, and ancillary economic growth in communities for many years to come. Finally, to note, while there have been put in place a number of federal assistance programs to support a wide range of businesses during this pandemic, and despite the efforts of industry groups and certain congressional leaders, cannabis businesses are still not able to avail themselves of the benefits of the Federal EIDL, PPP or agricultural support programs given the status of cannabis as a Schedule 1 controlled substance. Secondly, regarding the industry dynamics during this pandemic. First off, our tenants and their dedicated teams have done tremendous work, day in and day out, providing access to cannabis for patients and consumers, while working tirelessly to implement protocols and procedures designed to protect the health of patients, consumers, and employees. Our tenants were able to quickly adapt to this new environment, instituting social distancing and further enhanced sanitation procedures as well as implementing online ordering, advanced scheduling, curbside pickup, and delivery, to name just a few of these changes. And while there certainly have been significant disruptions on state and local levels, such as with the Massachusetts shutdown of adult-use cannabis operations, the industry as a whole has demonstrated tremendous resilience in the face of one of the greatest health and economic challenges our country has faced. On a macro level, legal cannabis is one of the very few sectors in the economy that has held up well in this current environment, notwithstanding the complete lack of federal support as afforded to nearly all other industries. That said, there certainly has been a good amount of variation in performance across states, driven by several factors including the adaptability of state and local governments to accommodate curbside pickup and delivery, the breadth and duration of stay-at-home orders, and COVID infection rates, among others. For example, the state of Nevada has experienced a precipitous decline in tourism, which has had a significant dampening effect on the state's adult-use cannabis market. And of course, in Massachusetts, adult-use stores were required to close for a few months by state authorities, which had a very significant impact on sales. At the same time, states like Maryland and Pennsylvania continue to exhibit tremendous growth and resiliency each month in service of patients. We also continue to see consolidation of the industry, which has been a theme for a number of months now and continued challenges in the capital markets for cannabis operators. Within our portfolio, we have seen some of that consolidation play out with Curaleaf closing on its acquisition of Grassroots late last month and Columbia Care's pending acquisition of the Green Solution, all of whom are our tenants. We expect that strong brands and strong balance sheets will provide further differentiation in this environment in the months to come. We are certainly proud to work with many of the best-in-class operators, and we have continued our strategy of focusing on developing and expanding our real estate partnerships with strong, well-positioned multistate operators, as Ben will describe in some detail. While this is an extremely challenging time for our country and our world, we believe that the regulated cannabis industry has exhibited exceptional resilience in this crisis to date and will continue to thrive and be one of the top long-term drivers of growth and good jobs across the country. And it bears repeating again, what an exceptional growth opportunity the U.S. regulated cannabis industry represents. Arcview and BDS forecast growth from $9.1 billion in 2018 to over $31.4 billion in 2024, a compound annual growth rate of nearly 23%. It is really difficult to draw a comparison to any industry in the world that represents such an opportunity. I'll now turn the call over to Ben who will walk you through our recent acquisitions and follow-on investments in our property portfolio.

Thanks, Paul. As Alan noted, since April 1, we have acquired 8 properties in 5 states, representing a mix of expansion of our existing real estate partnerships with top operators and the establishment of new tenant relationships. As of today, we own 61 properties across 16 states, representing approximately 4.5 million square feet, including approximately 1.5 million square feet under development or redevelopment. Similar to past calls, I plan to touch on each of our acquisitions by state and also provide some information about each tenant and our portfolio overall in the state. As we previously announced just last month, we entered into our 16th state, acquiring 3 properties in New Jersey. We acquired a 111,000-square-foot industrial property and entered into a long-term lease with Curaleaf with our total investment in the acquisition and tenant improvements at the property expected to be $35 million in the aggregate. Curaleaf is a leading multistate operator and late last month announced the closing of its acquisition of Grassroots, another tenant of ours in Illinois, Pennsylvania, and North Dakota. Curaleaf and Grassroots together have a presence in 23 states with over 135 dispensary licenses, 88 operational dispensary locations, and over 30 processing facilities and 22 cultivation sites, comprising 1.6 million square feet of cultivation capacity. In total, we have long-term leases at 4 of our properties with Curaleaf and Grassroots, representing a total investment of a little over $100 million, including commitments to fund future tenant improvements. Shortly after our Curaleaf transaction, we completed the acquisitions of 2 properties in sale-leaseback transactions with Columbia Care, another strong multistate operator. As you may know, Columbia Care is in the process of acquiring the Green Solution, a tenant of ours in Colorado. Columbia Care and the Green Solution together are expected to operate in 18 jurisdictions with over 70 U.S. dispensary locations, 22 cultivation and processing facilities, 1 million square feet of cultivation production capacity, and over 1,300 employees. These 3 transactions in New Jersey represent a total investment of just under $50 million, including commitments to fund future tenant improvements. New Jersey represents the 16th state where we own properties, and we are excited about the market potential for both the current medical-use program and the prospects for the introduction of an adult-use program. Governor Phil Murphy has taken important steps to improve and expand access for patients under the medical-use program, and legalization of adult-use cannabis is on the ballot this November for residents of New Jersey, with recent polling showing a strong majority of support. Now to Massachusetts. As we discussed on our last call, in April, we acquired a 199,000-square-foot industrial property and entered into a long-term lease with Ascend Wellness, with our total investment in the acquisition and tenant improvements at the property expected to be $49 million in the aggregate. Ascend is a vertically integrated MSO with retail and cultivation operations in Massachusetts, Illinois, Ohio, and Michigan. This transaction represented our third acquisition and lease with Ascend, having previously acquired and entered into long-term leases with Ascend for their cannabis cultivation and processing facilities in Illinois and Michigan. And at the very end of the quarter, we closed on a 118,000-square-foot industrial property and executed a long-term lease with Cresco Labs, with our total investment in the acquisition and tenant improvements at the property expected to be a little under $29 million. This transaction marked the fifth acquisition and lease with Cresco, having previously entered into acquisitions and leases for Cresco's cannabis cultivation and processing facilities in Illinois, Michigan, and Ohio. As of today, we have 5 properties in Massachusetts, and our total investment, including committed funding for future tenant improvements, is $166 million, including the additional $17 million, which may be requested by Trulieve at our Holy Oak property. These 5 properties are also leased to some of the top regulated cannabis operators in the United States including Ascend, Cresco, Holistic Industries, PharmaCann, and Trulieve. As Paul previously noted, Massachusetts determined to keep medical-use cannabis businesses open as an essential service and to close adult-use cannabis stores for approximately 2 months, with adult-use cannabis stores reopening in late May. Now for Michigan. As discussed on our last call, in April, we acquired a 115,000-square-foot industrial property in a sale-leaseback transaction with Cresco, with our total investment in the acquisition and tenant improvements at the property expected to be $32 million in the aggregate after our recent amendment to increase the tenant improvement allowance by an additional $16 million. As of today, our total investment, including committed funding for future tenant improvements for the properties we own in Michigan, is about $131 million. Michigan has allowed both adult-use and medical-use cannabis businesses to remain open, and according to a Michigan Marijuana Regulatory Agency report, June 2020 total sales for medical-use and adult-use cannabis were approximately $90 million, or over $1 billion on an annualized basis compared to total regulated sales of about $35 million during January of this year. We believe these statistics demonstrate the resiliency of the cannabis industry against the backdrop of a very difficult economic environment. On to Pennsylvania. In early June, we closed on our third acquisition and lease with Holistic Industries for a 108,000-square-foot industrial property in Newcastle, with our total investment in the acquisition and tenant improvements at the property expected to be a little over $15 million in the aggregate. We previously acquired and leased Holistic's cannabis cultivation and processing facilities in Maryland and Massachusetts. Holistic is one of the largest private vertically integrated MSOs in the U.S., with operations in California, Maryland, Massachusetts, Michigan, Pennsylvania, and Washington D.C. A little later in June, we expanded our investment with Green Leaf Medical at our Saxton facility, a 266,000-square-foot industrial facility. Green Leaf previously redeveloped 103,000 square feet of the facility for medical-use cannabis cultivation and processing, and we are providing Green Leaf $30 million in funding for the redevelopment of the remaining 163,000 square feet. We also leased to Green Leaf our property in Richmond, Virginia, an 82,000-square-foot cultivation, processing, and dispensing facility that we acquired earlier this year. Pennsylvania state authorities have done an excellent job of fostering the growth and expansion of access to patients throughout the state. As of the end of June, there were 330,000 registered patients. According to Marijuana Business Daily, medical cannabis sales are expected to nearly double this year, approaching $400 million. With a large majority of Pennsylvania's pulling in support of legalization of adult-use as well, last month, the majority of Pennsylvania State Democrats sent a letter to the Governor and legislative leaders to pursue adult-use legalization, in part to generate much-needed tax revenue to help offset losses stemming from the current pandemic. Multiple bills legalizing adult-use are pending in Pennsylvania's legislature. Now for California. In May, we acquired a 70,000-square-foot industrial property in Southern California for $17.5 million and entered into a long-term lease with Kings Garden. Including this property, we leased 5 properties to Kings Garden, including the 4-property industrial portfolio totaling 102,000 square feet that we acquired in April of last year. Kings Garden is a leading cannabis cultivation, processing, and manufacturing operator, having developed a tremendous brand and reputation for consistent top-shelf quality. Notably and highly unique in this industry, Kings Garden declared its first quarterly dividend in June of this year to its equity investors. Finally, as Alan mentioned at the beginning of this call, and as we disclosed in our press release yesterday, we are in advanced discussions with Holistic, our tenant partner in Maryland, Massachusetts, and Pennsylvania to lease our Los Angeles property. Holistic has executed an agreement to acquire the retail distribution, cultivation, and manufacturing licenses from the former tenant of the property, which is in receivership. A court date has been established for the approval of the sale of the licenses in the coming weeks, and we expect the transaction to close a few weeks after that approval. Nothing is certain at this point, but we are optimistic that we will be able to make a definitive announcement in the near future. In terms of overall pipeline, we continue to see a very strong demand for our real estate capital solutions and are in active negotiations with a number of top-tier operators, both existing tenants and new ones, and look forward to sharing additional transactions as we complete them in the months to come, continuing to utilize the strength of our balance sheet. With that, I'll turn it over to Catherine.

Thanks, Ben. It's been yet another busy quarter, and the regulated cannabis market has really shown its resiliency during these unprecedented times, both of which are reflected in our financial results for the second quarter and 6 months year-to-date. We generated total revenues of approximately $24.3 million for the quarter, a 183% increase from Q2 of last year. The increase was driven primarily by the acquisition and leasing of new properties, additional tenant improvement allowances provided to tenants at certain properties that resulted in base rent adjustments, and contractual rent escalations at certain properties, offset by temporary rent deferrals. As we discussed on our last call, we've been in close discussions with each of our tenants during these unprecedented times and executed temporary rent deferrals for 3 of our 23 tenants, generally structured to apply a portion of the security deposit we hold under each lease to pay April rent in full, defer rent for May and June in full, and provide for the pro-rata repayment of the security deposit and deferred rent over an 18-month time period starting July 1, 2020. Pursuant to these amendments, a total of $743,000 of security deposits that we hold in cash were applied to the payment of rent for April, and a total of $1.5 million in rent was deferred for May and June. The total amount of $2.3 million from these amendments represents approximately 2.5% of our total revenues annualized as reported for Q2. As Alan mentioned, we've collected 100% of contractually due rent across our total portfolio for the months of April, May, June, and July, other than for our Los Angeles property, including full repayment of July rent and pro-rata repayments of the security deposit and deferred rent from the 3 tenants that were under the rent deferral program. We have also not executed rent deferrals for any additional tenants other than these 3 tenants. As we've indicated in the past, our Q2 revenue reflects only partial quarters of revenues from the acquisitions and leases executed during the quarter and no revenues, of course, for the leases executed after the end of the quarter. Our revenues for the quarter were also impacted by rent abatements or deferrals under certain leases that are expected to burn off in the next few months as we continue to account for all of our leases on a cash basis. For the 3 months ended June 30, 2020, we recorded net income of $13 million. Funds from operations, which adds back property depreciation to net income, were $19.7 million. Adjusted funds from operations, which adds back noncash stock-based compensation expense and noncash interest expense related to our exchangeable senior notes, were $21 million. For the 3 months ended June 30, 2020, adjusted funds from operations grew 263% from the prior year period. On July 15, we paid our quarterly dividend of $1.06 per share to common shareholders of record as of June 30. The Q2 2020 common stock dividend reflects a 77% increase from the prior year's second quarter. As we've indicated in the past, the Board continues to target a dividend payout ratio of 75% to 85% of AFFO on a stabilized portfolio basis. During the quarter, we also continued to fund real estate improvements into many of our properties as offered in tenant improvement allowances or construction development to our operators under our leases. As we previously noted, these improvements are critical to either redeveloping an existing facility to a cannabis facility or funding expansion to address growing market demands. As Ben previously mentioned, we've been proud to partner with many of our tenant operators and amend the leases to provide for additional expansion capital at our facilities for a corresponding increase in base rent. During the 6 months ended June 30, 2020, we capitalized costs of approximately $158.4 million and funded approximately $161 million relating to tenant improvements and construction activity at our properties. With respect to financing activity, in May, we completed a follow-on public offering of common stock, raising net proceeds of about $115 million, including the exercise in full of our underwriters' option to purchase additional shares. In July, we completed another follow-on public offering of common stock, raising gross proceeds of about $259 million, including the exercise in full of our underwriters' option to purchase additional shares. This brings our total capital raised to approximately $1.4 billion from the IPO follow-on common stock offerings, our Series A preferred stock, exchangeable senior notes, and our ATM program. To date, we've committed around 77% of our raised capital or approximately $1.1 billion in the aggregate under our leases. We are truly grateful for all of our stakeholders' continued support, and we're focused on investing the proceeds from our recent equity raises with the best tenants and working closely with our tenants to navigate through these unprecedented times and come out even stronger on the other end. Finally, as highlighted on our last call, I'd like to note that we remain very conservatively leveraged with no secured debt and approximately 12% of our total gross assets consisting of our exchangeable senior notes at quarter end, a leverage rate and balance sheet composition that is truly unique among real estate companies. Those exchangeable notes have a fixed cash interest rate of 3.75%, equating to approximately $5.4 million of total cash interest payments per year and do not mature until 2024. Those exchangeable senior notes, the only debt we have on the balance sheet totaling $1.2 billion of assets as of quarter end. With that, I'll turn it back to Alan.

Thanks, Catherine. As we have highlighted in prior calls, I'd like to note the following in closing. We are proud of everything that our tenants have accomplished and commend them in the way that they have adapted to this ongoing pandemic to continue to provide safe and reliable access to patients and consumers. We are well-capitalized with a strong, flexible balance sheet that we see as a tremendous asset to allow us to weather these uncertain times and continue to support our tenants and the industry as a whole and its continued expansion. We believe the last few months have demonstrated the tremendous resiliency of this industry, and we are steadfast in our belief of its very bright, long-term future. I want to personally thank our shareholders for your continued support and entrusting us as stewards of your investment. We have and will continue to do our very best in that role every day. With that, I'd like to open it up for questions. Operator, could you please open the call up for questions?

Our first question today comes from Tom Catherwood with BTIG.

So I don't want to talk politics here, but taking a step back, the DNC voted down federal legalization from its 2020 platform recently. And it's that it supports decriminalization and then rescheduling through executive action, primarily targeted at medical cannabis. So in relation to your portfolio, how could decriminalization or rescheduling impact your business? And would it expose your tenants to competition from interstate commerce or import of cannabis from other countries?

Tom, it's Paul. Yes, it's interesting to see that the DNC has largely adopted the Biden-Sanders policy, which wasn't surprising. We were pleased to review the Biden-Sanders proposal alongside the DNC's. They are suggesting that medical cannabis should be legal across all 50 states, allowing doctors to recommend cannabis without federal interference. We view this as a significant positive for our business and the industry, as it paves the way for medical cannabis in all states without needing to hold a vote. However, this doesn't involve descheduling cannabis, which would prevent the establishment of interstate commerce. If this plan is realized next year with Biden's election and a Democratic Senate, we anticipate some changes that appear favorable since there won't be a full descheduling of cannabis. It seems the Biden administration is leaning towards the STATES Act instead of the MORE Act, which would leave the decision regarding recreational cannabis to individual states. Overall, we see this as a positive development for the industry and our tenant operators.

Got it. And then next one is, this goes back a bit, but if I recall correctly, when MedMen was going to acquire PharmaCann, you had signed a tri-party agreement to govern how PharmaCann's leases would be handled after that transaction. With Curaleaf closing on Grassroots, which you mentioned and, obviously, Columbia Care with TGS and even with the announced deal between Jushi Holdings and Vireo in Pennsylvania, how are you addressing your leases during changes in ownership? And do you get any additional credit enhancements or increased corporate guarantees?

To clarify, there was no tri-party agreement with MedMen and Treehouse at that time. All of our leases include a corporate guarantee, which allows us to assess any new entity involved in our transactions. The guarantee remains in effect unless we determine that the new entity acquiring one of our leases is in a stronger financial position than the previous one. Therefore, leases require our approval whenever an acquisition takes place. The corporate guarantees remain in effect and transfer appropriately. If we reach an agreement with the new entity, they then become the new corporate guarantor for the existing leases.

Got it. Okay. So I would assume that if you approve the lease transfer and receive the new corporate guarantee from the new entity, the other terms will remain unchanged, including rents, rent increases up to that time, and lease duration, all of which will be consistent with the original agreement, correct?

Yes. Other than one lease where the tenant has a purchase option, all of our lease terms do not include early termination rights. There are no changes or pre-agreed modifications to any lease.

Got it. And then maybe for Paul here. In regards to your asset at 1500 Esperanza Street, great to hear that Holistic is under contract to acquire those licenses. It seems very similar to Holistic's first deal in California in 2018. But help me understand the receivership process. If I recall correctly, throughout this process, it sounded like there was reverse inquiries and interest on your space. But at the same point in time, the licenses and the processing of the receiver held up agreements. Is the process that the licenses and the assets that are under receivership have to be resolved before you can lease the space? Or is that just a process that you've decided to follow? How did that work exactly?

Yes. So it's been a long process, certainly, and it hasn't been helped by the COVID shutdowns with some of the administrative offices in Los Angeles and with the receiver. So we've been working closely with the receiver, and we're very happy to see Holistic's interest in the property. But at this point, it's still not a done deal. We're optimistic it will close. When the receiver gets final court approval of the transfer of the licenses to Holistic, we'll then be in a position to talk about the lease, but it's premature for us now to discuss the lease terms.

To elaborate on that specific transaction, it was further complicated by the Canadian owner's initiation of the receivership process in Canada. Once that process was adjudicated, the owner became the primary investor or capital provider for the former tenant. Additionally, a second receivership was initiated in California and Los Angeles, which added another layer of complexity on top of the impact from COVID and the limited access to courts and administrative procedures in California. Typically, we wouldn't encounter this level of complication.

Got it. That's really helpful. And then last one for me, for Ben. You may not have this kind of at your fingertips right now, but you spoke a lot about tenant expansions. So whether it's Phase 2 or Phase 3 of someone building out their space, it obviously seems to be a great source of investment in your portfolio. Do you have a sense of how much expansion potential there is within the assets that you already own, whether it's fitting out space that already exists or greenfield expansion on additional acreage? Do you have any sense of that?

Yes. So we're continuing to see a real nice mix in the pipeline between expansion in our existing facilities and new investments. Similar to many aspects of the business, it's very much driven by the state-by-state markets, and as we continue to see specific states, we saw a lot in Illinois. As an example, late last year, I think we'll see a lot of that in the Midwest and East Coast medical states continuing this year. The increase in the market is driving a lot of demand for the real estate capital to expand these facilities, and it is part of our underwriting going in on the acquisition that the site or the building itself will be able to support where we see the market going over the long term.

Seeing no further questions, I would like to hand the call back over to Alan Gold for any closing remarks.

Thank you. And thank you all for joining us today. I'd also like to again thank our stakeholders and our shareholders for your continued support. And very importantly, to also thank all the employees for all their hard work in getting it and having such a successful quarter and the growth of this company. So thank you. And with that, we will sign off.

The conference has now concluded. Thank you for attending today's presentation. You may now disconnect.